Clinical Trials Browser

Phase 1/2 × INDUSTRY × amivantamab × Clear all

NCT05488314 2026-03-13

METalmark

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05908734 2026-03-13

PolyDamas

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07227025 2026-03-13

KaRAnaSa

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung